Literature DB >> 25690514

Blood transfusion and risk of infection in frail elderly after hip fracture surgery: the TRIFE randomized controlled trial.

Merete Gregersen1, Else Marie Damsgaard, Lars Carl Borris.   

Abstract

OBJECTIVES: It is still under debate that red blood cell (RBC) transfusions might increase the risk of healthcare-associated infections after hip fracture surgery. Previously, we found that a liberal RBC transfusion strategy improved survival in nursing home residents. Our aim, therefore, was to investigate whether a more liberal RBC transfusion strategy was associated with a higher infection risk in frail elderly hip fracture patients.
DESIGN: Prospective, assessor-blinded, randomized and controlled trial. SETTINGS: Orthopedic ward, Geriatric ward, and Hospital-at-home. PATIENTS: 284 consecutively hospital-admitted elderly with hip fracture from nursing homes or sheltered housing facilities were included. INTERVENTION: A restrictive RBC transfusion strategy (hemoglobin <9.7 g/dL; 6 mmol/L) compared with a liberal strategy (hemoglobin <11.3 g/dL; 7 mmol/L) administered within 30 days after surgery. MAIN OUTCOME MEASUREMENTS: Leukocytes and C-reactive protein (CRP) in repeated blood samples within 30 days, and number of all infections (pneumonia, urinary tract infection, and other infections) within 10 days.
RESULTS: 88 % of the patients received a RBC transfusion. A median of 1 RBC unit (interquartile range (IQR): 1-2) was transfused for the restrictive strategy group versus 3 RBC units (IQR: 2-5) for the liberal group. Leukocytes and CRP measurements were similar for both groups. Rates of infection were 72 % for the restrictive group compared to 66 % for the liberal group (risk ratio 1.08; 95 % confidence interval 0.93-1.27, p value 0.29).
CONCLUSIONS: A more liberal RBC transfusion strategy was not associated with higher risk of infection among residents from nursing homes or sheltered housing undergoing hip fracture surgery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25690514     DOI: 10.1007/s00590-015-1609-2

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  28 in total

1.  Liberal or restrictive transfusion in high-risk patients after hip surgery.

Authors:  Jeffrey L Carson; Michael L Terrin; Helaine Noveck; David W Sanders; Bernard R Chaitman; George G Rhoads; George Nemo; Karen Dragert; Lauren Beaupre; Kevin Hildebrand; William Macaulay; Courtland Lewis; Donald Richard Cook; Gwendolyn Dobbin; Khwaja J Zakriya; Fred S Apple; Rebecca A Horney; Jay Magaziner
Journal:  N Engl J Med       Date:  2011-12-14       Impact factor: 91.245

2.  Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture.

Authors:  Ethan A Halm; Jason J Wang; Kenneth Boockvar; Joan Penrod; Stacey B Silberzweig; Jay Magaziner; Kenneth J Koval; Albert L Siu
Journal:  Transfusion       Date:  2003-10       Impact factor: 3.157

3.  The association of preoperative anemia and perioperative allogeneic blood transfusion with the risk of surgical site infection.

Authors:  Walter P Weber; Marcel Zwahlen; Stefan Reck; Heidi Misteli; Rachel Rosenthal; Andreas S Buser; Mark Kaufmann; Daniel Oertli; Andreas F Widmer; Walter R Marti
Journal:  Transfusion       Date:  2009-05-11       Impact factor: 3.157

4.  Blood transfusion and risk of infection: new convincing evidence.

Authors:  Jeffrey L Carson
Journal:  JAMA       Date:  2014-04-02       Impact factor: 56.272

Review 5.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Jeffrey L Carson; Paul A Carless; Paul C Hebert
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

6.  Allogenic blood transfusion does not predispose to infection after cardiac surgery.

Authors:  Ziad A Ali; Eric Lim; Reza Motalleb-Zadeh; Ayyaz A Ali; Chris J Callaghan; Caroline Gerrard; Alain Vuylsteke; Juliet Foweraker; Steven Tsui
Journal:  Ann Thorac Surg       Date:  2004-11       Impact factor: 4.330

7.  Blood transfusion requirements in elderly hip fracture patients.

Authors:  Abraham Adunsky; Anatolie Lichtenstein; Eli Mizrahi; Marina Arad; Michael Heim
Journal:  Arch Gerontol Geriatr       Date:  2003 Jan-Feb       Impact factor: 3.250

8.  Anaemia impedes functional mobility after hip fracture surgery.

Authors:  Nicolai B Foss; Morten Tange Kristensen; Henrik Kehlet
Journal:  Age Ageing       Date:  2008-03       Impact factor: 10.668

9.  Transfusion strategies for acute upper gastrointestinal bleeding.

Authors:  Càndid Villanueva; Alan Colomo; Alba Bosch; Mar Concepción; Virginia Hernandez-Gea; Carles Aracil; Isabel Graupera; María Poca; Cristina Alvarez-Urturi; Jordi Gordillo; Carlos Guarner-Argente; Miquel Santaló; Eduardo Muñiz; Carlos Guarner
Journal:  N Engl J Med       Date:  2013-01-03       Impact factor: 91.245

10.  [Relationship between allogeneic blood transfusion, iron deficiency and nosocomial infection in patients with hip fracture].

Authors:  Mónica Izuel Rami; José Antonio García Erce; Manuel Gómez-Barrera; Jorge Cuenca Espiérrez; Reyes Abad Sazatornil; María José Rabanaque Hernández
Journal:  Med Clin (Barc)       Date:  2008-11-15       Impact factor: 1.725

View more
  16 in total

1.  Hip fractures in 2016, where do we stand and have we made any progress?

Authors:  Cyril Mauffrey; Steven Stacey; Mark Hake; David Hak
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-03-09

2.  The best cited articles of the European Journal of Orthopaedic Surgery and Traumatology (EJOST): a bibliometric analysis.

Authors:  Andreas F Mavrogenis; Panayiotis D Megaloikonomos; Cyril Mauffrey; Marius M Scarlat; Patrick Simon; Kazuhiro Hasegawa; Samo K Fokter; Pierre Kehr
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-02-14

Review 3.  [Perioperative patient management in orthogeriatrics].

Authors:  P Moldzio; J Peters
Journal:  Orthopade       Date:  2017-01       Impact factor: 1.087

Review 4.  Transfusion thresholds for guiding red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Jane A Dennis; Marialena Trivella; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Dorée; Paul C Hébert
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

Review 5.  Mortality, Morbidity and Related Outcomes Following Perioperative Blood Transfusion in Patients with Major Orthopaedic Surgery: A Systematic Review.

Authors:  Susanne Müller; Doris Oberle; Ursula Drechsel-Bäuerle; Jutta Pavel; Brigitte Keller-Stanislawski; Markus B Funk
Journal:  Transfus Med Hemother       Date:  2018-02-28       Impact factor: 3.747

Review 6.  Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.

Authors:  Jeffrey L Carson; Simon J Stanworth; Nareg Roubinian; Dean A Fergusson; Darrell Triulzi; Carolyn Doree; Paul C Hebert
Journal:  Cochrane Database Syst Rev       Date:  2016-10-12

Review 7.  Interventions to improve the outcomes of frail people having surgery: A systematic review.

Authors:  Daniel I McIsaac; Tim Jen; Nikhile Mookerji; Abhilasha Patel; Manoj M Lalu
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

Review 8.  Anemia and blood transfusion in the critically ill patient with cardiovascular disease.

Authors:  Annemarie B Docherty; Timothy S Walsh
Journal:  Crit Care       Date:  2017-03-21       Impact factor: 9.097

Review 9.  Effect of restrictive versus liberal transfusion strategies on outcomes in patients with cardiovascular disease in a non-cardiac surgery setting: systematic review and meta-analysis.

Authors:  Annemarie B Docherty; Rob O'Donnell; Susan Brunskill; Marialena Trivella; Carolyn Doree; Lars Holst; Martyn Parker; Merete Gregersen; Juliano Pinheiro de Almeida; Timothy S Walsh; Simon J Stanworth
Journal:  BMJ       Date:  2016-03-29

Review 10.  What do we know about frailty in the acute care setting? A scoping review.

Authors:  Olga Theou; Emma Squires; Kayla Mallery; Jacques S Lee; Sherri Fay; Judah Goldstein; Joshua J Armstrong; Kenneth Rockwood
Journal:  BMC Geriatr       Date:  2018-06-11       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.